EUVIMEDEUVIMED entdecken
Open Access

Characteristics of HCC Patients with Portal Vein Thrombosis: Albumin and Survival

Brian Carr, Rossella Donghia, Sezai Yilmaz

Oncology · 2024

DOI: 10.1159/000542774 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology, 2024. Verfasst von Brian Carr und 2 weiteren Autor:innen. Beteiligte Einrichtung: Liver Transplant Institute, Inonu University Faculty of Medicine, Malatya, Turkey. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Portal Vein, Venous Thrombosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Presence of macroscopic portal vein thrombosis (PVT) in patients with hepatocellular carcinoma (HCC) has been found to be a major poor prognosis characteristic.

Aims

The aim of the study was to examine patients with PVT for their clinical characteristics and factors related to both PVT and survival.

Methods

A large HCC database containing 1,094 patients with PVT and 2,513 patients without PVT was examined. Patients had routine baseline serum liver parameters and alpha-fetoprotein (AFP) levels measured, as well as radiological assessment of maximum tumor diameter (MTD), tumor number, presence of macroscopic PVT, plus survival.

Results

The percent of patients with PVT increased with increase in both MTD and serum AFP levels and liver parameter levels were worse in patients with PVT than without it. A logistic regression model showed that the combination of MTD >5 cm plus AFP >100 IU/mL plus albumin

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsPortal VeinVenous ThrombosisSerum AlbuminHumansMaleFemaleMiddle Agedalpha-FetoproteinsAgedPrognosisProportional Hazards ModelsAdult

Stichwörter der Autor:innen

Alpha-fetoproteinHepatocellular carcinomaMultifocalityPlatelet-to-lymphocyte ratioPortal vein thrombosisSurvival

Substanzen

alpha-FetoproteinsSerum Albumin

Autor:innen und Institutionen

  • Liver Transplant Institute, Inonu University Faculty of Medicine, Malatya, Turkey.
  • National Institute of Gastroenterology, IRCCS "Saverio de Bellis", Bari, Italy.
  • Department of Surgery, Inonu University Faculty of Medicine, Malatya, Turkey.

Förderung

  • NCI NIH HHS

Zitieren

APA

Carr, B., Donghia, R., & Yilmaz, S. (2024). Characteristics of HCC Patients with Portal Vein Thrombosis: Albumin and Survival. Oncology. https://doi.org/10.1159/000542774

Vancouver

Carr B, Donghia R, Yilmaz S. Characteristics of HCC Patients with Portal Vein Thrombosis: Albumin and Survival. Oncology. 2024. doi:10.1159/000542774

BibTeX
@article{Carr2024,
  author = {Carr, Brian and Donghia, Rossella and Yilmaz, Sezai},
  title = {Characteristics of HCC Patients with Portal Vein Thrombosis: Albumin and Survival},
  journal = {Oncology},
  year = {2024},
  doi = {10.1159/000542774}
}
Kostenlos starten →